Trial Profile
Prospective study of lenalidomide and dexamethasone in patients with relapsed refractory multiple myeloma investigating immune cell response
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jan 2016
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Pharmacodynamics
- 22 Jan 2016 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology